Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Dyslipidaemia Drug Market to grow at a CAGR of 3.5 percent during the forecast period

(PharmaNewsWire.Com, September 04, 2023 ) The “Dyslipidaemia Drug Market” was valued USD 13.58 Bn in 2022 and is expected to grow at a CAGR of 3.5 percent over the forecast period to reach USD 17.76 Bn by 2029.

Dyslipidaemia Drug Market Scope and Research Methodology

The objective of the report is to present a comprehensive analysis of the Dyslipidaemia Drug Market. SWOT analysis was done to find strengths and weaknesses in the market. The market is segmented based on Drug Class, Distribution Channel, and Age Group.

Purchase Report :

Dyslipidaemia Drug Market Dynamics

Increased cardiovascular disease and high spending on research and development activities is expected to boost the Dyslipidaemia Drug Market growth. The high cost of drugs is expected to restrain the market growth.

Dyslipidaemia Drug Market Regional Insight

North America is expected to boost the Dyslipidaemia Drug market growth over the forecast period. An increasing number of patients suffering from dyslipidaemia is expected to boost the Dyslipidaemia Drug industry growth.

Purchase Report :

Dyslipidaemia Drug Market Segmentation

By Drug Class:


Bile Acid Sequestrants


Nicotinic Acid

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy


By Age Group:




Purchase Report :

Dyslipidaemia Drug Market Key Players Include

Pfizer Inc. - USA

Merck & Co., Inc. – USA

Bristol Myers Squibb (BMS) - USA

Regeneron Pharmaceuticals, Inc. - USA

Mylan N.V. - USA

Amgen Inc. - USA

Eli Lilly and Company - USA

AbbVie Inc. - USA

GlaxoSmithKline plc - United Kingdom

AstraZeneca - United Kingdom/Sweden

Novartis International AG - Switzerland

Sanofi - France

Boehringer Ingelheim - Germany

Teva Pharmaceutical Industries Ltd. - Israel

Sun Pharmaceutical Industries Ltd. - India

Lupin Limited - India

Maximize Market Research is leading Information Biotechnology research firm, has also published the following reports:

Lifestyle Drugs Market: The market size is expected to reach USD 163.52 Bn by 2029 at a CAGR of 7.1 percent during the forecast period.

Dystonia Drugs Market: The total market size is expected to reach USD 15.1 Mn by 2029 at a CAGR of 6.8 percent over the forecast period.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.


Dnyaneshwari Yevale


Source: EmailWire.Com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today! is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC